STELARA®
(ustekinumab)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
STELARA® (ustekinumab)
Medical Information
Stability of IV Formulation of STELARA in D5W
Last Updated: 01/02/2025
Summary
Janssen Biotech, Inc. has no data pertaining to the stability of STELARA when diluted with 5% dextrose in water (D5W) solution for intravenous (IV) administration